Bridge Pharmaceuticals

Bridge Pharmaceuticals is a drug development research institution headquartered in Gaithersburg, Maryland. It provides toxicology and pharmacology services to support Investigational New Drug (IND) applications worldwide. The company conducts drug development and preclinical services, including short-term and long-term in vivo studies ranging from acute to carcinogenicity protocols.